Intravenous fenoldopam for early acute kidney injury after liver transplantation
- 30 November 2014
- journal article
- Published by Springer Science and Business Media LLC in Journal of Anesthesia
- Vol. 29 (3), 426-432
- https://doi.org/10.1007/s00540-014-1951-2
Abstract
Acute kidney injury remains a serious complication after orthotopic liver transplantation. To date, several ‘renal-protective’ agents have been explored in this setting but with conflicting and disappointing results. Therefore, our aim is to evaluate the effects of fenoldopam in liver transplant patients with an established renal injury. In this prospective study, intravenous fenoldopam 0.1 µg/kg/min was administered to consecutive liver transplant patients with postoperative (within 7 days from surgery) stage 2 acute kidney injury (AKI) according to the Acute Kidney Injury Network classification. Actual glomerular filtration rate (GFR; calculated by the iohexol plasma clearance), serum creatinine (SCr) and cystatin C (SCyC) were used to assess the effect of the medication on the patients. During the study, 295 patients underwent liver transplant. Fifty-one patients (17.6 %) met the inclusion criteria and the data from 48 patients were analysed. SCr and SCyC levels decreased (p p p p We showed that fenoldopam was capable of improving some renal function parameters in postoperative liver transplantation patients with on-going AKI. This preliminary study now sets the stage for a multicenter, randomized, placebo-controlled trial in order to provide definite evidence.Keywords
This publication has 36 references indexed in Scilit:
- Routine Determination of GFR in Renal Transplant Recipients by HPLC Quantification of Plasma Iohexol Concentrations and Comparison With Estimated GFRJournal of Clinical Laboratory Analysis, 2012
- Lessons from liver transplantationAnaesthesia, 2012
- High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgeryCritical Care, 2011
- Acute kidney injury after procedures of orthotopic liver transplantation.Annals of Transplantation, 2011
- The model for end-stage liver disease (MELD)Hepatology, 2007
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Fenoldopam Mesylate and Renal Function in Patients Undergoing Liver Transplantation: A Randomized, Controlled Pilot TrialAnesthesia & Analgesia, 2004
- Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patientsCritical Care Medicine, 2001
- Contrast media as markers of GFREuropean Radiology, 2001
- The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjectsCritical Care Medicine, 1999